SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: (Original Filing)
[NEWS RELEASEystar Bio-Pharmaceutical Reports Second Quarter 2011 Results $9.1 Million Top Line; $0.21 Diluted EPS; Expanded Direct Distribution andles Channels XIAN, CHINA August 23, 2011 -- -ystar Bio-Pharmaceuticalmpany (NASDAQ:SKBI) ("Skystar" or the "Company"), Second Quarter 2011 Highlights Revenuereases 10% YoY to $9.1 million Veterinary vaccines totaled $0.4million, up 1.2% YoY]